Predicting ICU and ventilator needs through 2040
This study looks back at patients in the ICU from 2005 to 2023 to better predict how many days future patients might need intensive care or a breathing machine. Understanding these patterns could help hospitals and doctors prepare for future needs.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You were admitted to an intensive care unit (ICU) between 2005 and 2023.
- Your ICU stay lasted at least 4 hours.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at why people are admitted to the intensive care unit (ICU) and whether the number of ICU beds affects how many patients are admitted. It reviews records of patients admitted over several years.
This study uses a computer model to analyze health data from ICU patients to help predict outcomes. It aims to improve care for critically ill patients.
This study asks ICU doctors, nurses, or other providers to give their best guess about what will happen to a patient who has been on a breathing machine for two weeks. The goal is to learn how healthcare teams think about recovery.
This trial looks at how doctors and nurses predict survival for critically ill patients in the intensive care unit, compared to a standard medical score. It may help understand the accuracy of these predictions.
This trial looks at how well doctors followed current guidelines to diagnose ventilator-associated pneumonia (a lung infection from a breathing tube) in ICU patients between 2022 and 2024. It aims to improve future care.
This study looks at patients who are in the ICU, on a breathing machine, and have a long-term health condition. It aims to use digital tools to better understand these high-risk patients and improve their care.
Hear when a new ICU Admission trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.